Fig. 2From: Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective studyThe ROC curve of CD4+ T cells, NK cells and Tregs before immunotherapyBack to article page